Day: May 8, 2024

Declares Dividend of $0.42 per share for Q1 2024; Represents Genco’s 19th Consecutive Quarterly Dividend Totaling $5.575 Per Share NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today reported its financial results for the three months March 31, 2024. First Quarter 2024 and Year-to-Date HighlightsDividend: Declared a $0.42 per share dividend for Q1 202419th consecutive quarterly payout Cumulative dividends of $5.575 per share or 25% of our share price1 Q1 2024 dividend is payable on or about May 30, 2024 to all shareholders of record as of May 22, 2024.Financial performance: Net income of $18.8 million for Q1 2024, or basic and diluted earnings per share...

Dallas, Texas, May 08, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $6.8 million, or $.14 per share, in the first quarter of 2024 compared to a net loss attributable to NL stockholders of $6.7 million, or $.14 per share, in the first quarter of 2023. NL results include an unrealized gain of $2.4 million in the first quarter of 2024 related to the change in value of marketable equity securities compared to an unrealized loss of $5.5 million in the first quarter of 2023. CompX net sales were $38.0 million in the first quarter of 2024 compared to $41.2 million in the first quarter of 2023. CompX net sales decreased due to lower Marine Components sales primarily to the towboat market, partially offset by higher Security Products to the government security market....

Conference Call to Begin Today at 5:00 p.m. (ET)1Q 2024 Total revenues of $66M; +63% vs. 1Q 2023 1Q 2024 Net income of $11M; Non-GAAP net income of $15M $304M of cash and cash equivalents and investments at March 31, 2024 In early April, repaid Midcap senior-secured debt and Mann Group convertible debt totaling approximately $37M FDA Fast Track designation and IND clearance received for MNKD-101DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 08, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today reported financial results for the quarter ended March 31, 2024. “We achieved our eighth consecutive quarter of revenue growth putting us on a run rate of over $250 million in revenue for 2024,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. “In the last week, we received Fast Track...

Quarterly Operating Revenues of $818.2 million, up 16%   Quarterly Net Income of $53.1 million, ROE of 14.0% Quarterly Diluted EPS of $1.63 per share, up 25% NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) — StoneX Group Inc. (the “Company”; NASDAQ: SNEX), a global financial services network that connects companies, organizations, traders and investors to the global market ecosystem through a unique blend of digital platforms, end-to-end clearing and execution services, high touch service and deep expertise, today announced its financial results for the fiscal year 2024 second quarter ended March 31, 2024. Sean M. O’Connor, the Company’s CEO, stated, “We are reporting solid results for our second fiscal quarter due in large part to the diversification of both our product offering and client base, with net income of $53.1 million, up 27%...

Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products FIRDAPSE® Q1 2024 Net Product Revenues of $66.8 Million, a 16.2% YoY Increase Robust Revenue Momentum for FIRDAPSE® Successfully Commenced the U.S. Launch of AGAMREE® on March 13, 2024 Reported AGAMREE® Q1 2024 Net Product Revenues of $1.2 Million for the First Two Weeks of Commercial Availability Early AGAMREE® Launch Indicators Highlight Promising Product Uptake Surpassing Initial Expectations Q1 2024 GAAP Net Income of $23.3 Million, $0.19 Per Share Diluted Q1 2024 Non-GAAP Net Income of $46.8 Million, $0.38 Per Share Diluted Reaffirm Full Year 2024 Total Revenue Guidance Between $455 Million and $475 Million Conference Call and Webcast to be Held on May 9, 2024, at 8:30 AM ET CORAL...

Q3 Total revenues of $187.0 million, an increase of 16% year-over-year, while expanding operating marginsQ3 Recurring revenue of $172.0 million, an increase of 14% year-over-yearFY’24 revenue guidance of $650 – $652 million, an increase of 18% year-over-year at the top end of the rangeCINCINNATI, May 08, 2024 (GLOBE NEWSWIRE) — Paycor HCM, Inc. (Nasdaq: PYCR) (“Paycor”), a leading provider of human capital management (“HCM”) software, today announced financial results for the third quarter fiscal year 2024, which ended March 31, 2024. “We delivered another strong quarter as our differentiated HCM solution that powers people and performance continued to resonate in the market,” said Raul Villar, Jr., Chief Executive Officer of Paycor. “Recurring revenue excluding form filings grew 20% year-over-year, driven by continued...

Maintains Full Year 2024 Outlook RICHARDSON, Texas, May 08, 2024 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) today announced financial results for the first quarter ended March 30, 2024. First Quarter SummaryFirst quarter worldwide net sales decreased to $255 million, down 22% on a reported basis and 21% in constant currency, reflecting five points of impact related to the Company’s strategic actions to exit the smartwatch category and optimize its retail store portfolio. Gross margins expanded 300 basis points to 52.4%, primarily reflecting progress under the Company’s Transform and Grow (“TAG”) Plan. Selling, general and administrative (“SG&A”) expenses of $152 million were down 20% versus last year mainly due to lower compensation costs as a result of efficiencies resulting from the Company’s TAG...

Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data at 2024 ASCO Annual Meeting; preparing for a potential phase 3 trial Zeno BLA accepted for priority review by the FDA for the treatment of NRG1+ NSCLC and PDAC Based on the Company’s current operating plan, existing cash, cash equivalents and marketable securities expected to fund Merus’ operations into 2027UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced financial results for the first quarter and provided a business update. “At the upcoming 2024 ASCO meeting, we are looking forward to presenting multiple datasets...

RAPID CITY, S.D., May 08, 2024 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced financial results for the first quarter of 2024. Net income available for common stock and earnings per share for the three months ended March 31, 2024, compared to the three months ended March 31, 2023, were:  Three Months Ended March 31,  2024   2023  (in millions, except per share amounts)Net income available for common stock $ 127.9   $ 114.1Earnings per share, Diluted $ 1.87   $ 1.73           First quarter earnings were $1.87 per share compared to $1.73 per share in the first quarter of 2023, an increase of 8%. Financial results were driven by new rates and rider recovery and lower operating expenses. These benefits more than offset the impact from 10% lower heating degree days, a prior year gain on sale of...

HOUSTON, May 08, 2024 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy, industrial and gas utilities end-markets, today announced first quarter 2024 results. Net income attributable to common stockholders for the first quarter of 2024 was $13 million, or $0.15 per diluted share, as compared to the first quarter of 2023 net income attributable to common stockholders of $28 million, or $0.33 per diluted share. Adjusted net income attributable to common stockholders for the first quarter of 2024 was $17 million, or $0.20 per diluted share, as compared to the first quarter of 2023 adjusted net income attributable to common stockholders of $27 million, or $0.32 per diluted share. MRC Global’s first quarter 2024 gross...